Skip to main content

Drug Interactions between influenza virus vaccine, h1n1, live and oseltamivir

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

oseltamivir influenza virus vaccine, H1N1, live

Applies to: oseltamivir and influenza virus vaccine, h1n1, live

Antiviral flu medications like oseltamivir may interfere with the immune response to influenza virus vaccine, H1N1, live. Individuals who have been treated with antiviral flu medications should generally not be vaccinated with influenza virus vaccine, H1N1, live until 24 to 48 hours after stopping treatment. The immunizing doctor should be informed of recent therapy with oseltamivir so that appropriate measures and/or precautions can be taken. Similarly, individuals who have been vaccinated with influenza virus vaccine, H1N1, live must generally wait two weeks before using antiviral flu medications unless otherwise directed by their doctor. If vaccination was given shortly before or during treatment with an antiviral flu medication, a revaccination may be necessary at some point. It is important to tell the doctor about all other medications being used, including vitamins and herbs. Do not stop using any medications without first talking to the doctor.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer